Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.

Rouby JJ, Zhu Y, Torres A, Rello J, Monsel A.

Open source

DOI
10.1186/s13613-022-01068-8
Published
2022-10-17
Container
Ann Intensive Care
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13613-022-01068-8,
  title = {Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.},
  author = {Rouby JJ and  Zhu Y and  Torres A and  Rello J and  Monsel A.},
  year = {2022},
  journal = {Ann Intensive Care},
  doi = {10.1186/s13613-022-01068-8},
  url = {https://doi.org/10.1186/s13613-022-01068-8}
}

RIS

TY  - JOUR
TI  - Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.
AU  - Rouby JJ
AU  -  Zhu Y
AU  -  Torres A
AU  -  Rello J
AU  -  Monsel A.
PY  - 2022
JO  - Ann Intensive Care
DO  - 10.1186/s13613-022-01068-8
UR  - https://doi.org/10.1186/s13613-022-01068-8
ER  - 

APA

JJ, R., Y, Z., A, T., J, R., & A., M. (2022). Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.. Ann Intensive Care. https://doi.org/10.1186/s13613-022-01068-8

Source records